UnitedHealth Group Inc (UNH) Shares Bought by Dorsey Wright & Associates

Dorsey Wright & Associates increased its position in UnitedHealth Group Inc (NYSE:UNH) by 23.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,355 shares of the healthcare conglomerate’s stock after buying an additional 2,742 shares during the quarter. Dorsey Wright & Associates’ holdings in UnitedHealth Group were worth $2,811,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Regal Wealth Group Inc. increased its holdings in UnitedHealth Group by 0.4% in the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after purchasing an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. increased its holdings in UnitedHealth Group by 0.4% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after purchasing an additional 4 shares in the last quarter. RB Capital Management LLC increased its holdings in UnitedHealth Group by 0.4% in the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after purchasing an additional 7 shares in the last quarter. RNC Capital Management LLC increased its holdings in UnitedHealth Group by 0.7% in the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares in the last quarter. Finally, Highland Private Wealth Management increased its holdings in UnitedHealth Group by 0.4% in the 2nd quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after purchasing an additional 13 shares in the last quarter. 86.21% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Inc (UNH) traded down $3.34 during trading hours on Friday, reaching $231.88. The company had a trading volume of 3,830,714 shares, compared to its average volume of 3,450,000. The firm has a market capitalization of $224,200.00, a P/E ratio of 21.65, a price-to-earnings-growth ratio of 1.37 and a beta of 0.70. UnitedHealth Group Inc has a fifty-two week low of $156.49 and a fifty-two week high of $250.79. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period last year, the firm earned $2.11 earnings per share. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Michele J. Hooper sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the completion of the transaction, the director now directly owns 37,284 shares in the company, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. Insiders sold 53,853 shares of company stock worth $12,358,508 in the last three months. 0.89% of the stock is currently owned by corporate insiders.

Several analysts have recently weighed in on UNH shares. Argus raised their target price on UnitedHealth Group from $215.00 to $230.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. Leerink Swann restated a “buy” rating and set a $240.00 target price (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Bank of America raised their target price on UnitedHealth Group from $230.00 to $240.00 and gave the company a “buy” rating in a research note on Wednesday, October 18th. Citigroup raised their target price on UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research note on Wednesday, October 18th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $208.00 target price on shares of UnitedHealth Group in a research note on Tuesday, October 17th. Two equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $243.22.

ILLEGAL ACTIVITY WARNING: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/02/03/unitedhealth-group-inc-unh-position-lifted-by-dorsey-wright-associates.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply